Curasight (CURAS) | Spotlight

Curasight is active in the pharmaceutical industry. The company specializes in research and development of various drug candidates. The product portfolio includes, for example, research and development within Positron Emission Tomography (PET) and related ancillary services. The business is operating with the largest presence within Scandinavia. Curasight is headquartered in Copenhagen.

Quotes for Curasight A/S

Right Now

+/-: -0.6
%: -1,94%
Latest: 30.3
High: 31
Low: 29.25
Volume: 24 673
Turnover (DKK): 739 233
Value (MDKK): 518,9

Board

CEO

Ulrich Krasilnikoff

Chairman Of The Board

Per Falholt

Board

Andreas Kjær
Charlotte Vedel
Lars Trolle
Ulrich Krasilnikoff

News

2020-12-21 15:54:46 Results from Phase II study in prostate cancer to be published in the Journal of Nuclear Medicine
2020-12-16 09:39:24 Japanese patent application 2019-005811 is accepted for grant
2020-12-15 08:00:00 Financial Calendar 2021
2020-11-30 08:00:00 Interim report January – September 2020
2020-11-11 15:14:56 Curasight initiates pre-clinical study on therapy (uTREAT[®]) in brain cancer and signs CRO-agreement

News agencies

2020-12-21 16:21:22 Finwire: Curasight-resultat i fas 2 ska publiceras i vetenskaplig tidskrift
2020-12-21 15:54:59 Ritzau: Results from Phase II study in prostate cancer to be published in the Journal of Nuclear Medicine
2020-12-16 10:23:57 Finwire: Curasight på väg få Utreat-patent godkänt i Japan
2020-12-16 09:39:32 Ritzau: Japanese patent application 2019-005811 is accepted for grant
2020-12-15 08:00:20 Ritzau: Financial Calendar 2021

Videos

Largest Owners

Name	Capital %	Votes %	Date
Andreas Kjaer	35,13	35,13	2020-10-08
Ulrich Krasilnikoff	24,16	24,16	2020-10-08
Carsten Haagen Nielsen	14,03	14,03	2020-10-08
Jacob Madsen	5,27	5,27	2020-10-08
Lars Trolle	3,43	3,43	2020-10-08
Måns Flodberg	0,61	0,61	2020-10-08
Per Falholt	0,20	0,20	2020-10-08
Charlotte Vedel	0,04	0,04	2020-10-08

Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Upcoming reports

2021-02-24 Bokslutskommuniké 2020
2021-03-25 Årsstämma 2020
2021-05-20 Delårsrapport 2021-Q1
2021-08-24 Delårsrapport 2021-Q2

Curasight A/S